Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers.

Human genomics

Volumn 3, Issue 1, 2008, Pages 7-16

  Aquilante, Christina L ^a   Bushman, Lane R ^a   Knutsen, Shannon D ^a   Burt, Lauren E ^a   Rome, Lucille Capo ^a   Kosmiski, Lisa A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CYP2C8 PROTEIN, HUMAN; ORGANIC ANION TRANSPORTER; ROSIGLITAZONE; SLCO1B1 PROTEIN, HUMAN; UNSPECIFIC MONOOXYGENASE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEALTH; HUMAN; MALE; MIDDLE AGED; TIME;

ADOLESCENT; ADULT; AREA UNDER CURVE; ARYL HYDROCARBON HYDROXYLASES; FEMALE; GENOTYPE; HEALTH; HUMANS; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, GENETIC; THIAZOLIDINEDIONES; TIME FACTORS;

MLCS; MLOWN;

EID: 63449139904     PISSN: None     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-3-1-7     Document Type: Article

References (0)